Novel Therapeutic Strategies for Neurodegenerative Disease
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 20 September 2024 | Viewed by 2234
Special Issue Editor
Interests: Alzheimer’s disease; mild cognitive impairment; cerebrospinal fluid; beta amyloid; neurodegenerative diseases; neurodegeneration; cognition disorders; event-related potentials; evoked potentials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Neurodegenerative diseases, including Alzheimer's disease, Frontotemporal dementia, Parkinson's disease and Amyotrophic lateral sclerosis, are each characterized by progressive degeneration and loss of specific subsets of neurons that lead to declines in brain function such as cognition and locomotor control. Despite intense research into Alzheimer’s disease (AD) and other dementias, there is no drug that effectively intervenes in the pathogenesis of the disease. Dementia and other neurodegenerative diseases that affect memory, cognition, and behavior are public health priorities throughout the developed world.
IJMS has organized a series of Special Issues to highlight the latest advancements in this area of science in order to be at the forefront of different fields of research. This editorial initiative of particular relevance, led by Professor Vasileios Papaliagkas, is focused on new insights, novel developments, current challenges, latest discoveries, recent advances, and future perspectives in the field of Neurodegenerative Disease.
The present Special Issue, entitled “Novel Therapeutic Strategies for Neurodegenerative Disease”, aims to present recent research developments on drugs or other innovative therapeutic strategies for treating AD and related dementias to those involved in this field and the wider community. We welcome contributions from original articles, reviews and case reports which focus on topics within this field.
Dr. Vasileios Papaliagkas
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neurodegenerative diseases
- Alzheimer’s disease
- Parkinson’s disease
- therapy
